Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 18 Sept 2026 for Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp., €37k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
David Kideckel: trading record in brief
David Kideckel is a declared insider at 3 companies; the most frequent names are Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp., Kane Biotech Inc. and Lobe Sciences Ltd. In total, 7 filings cover trades dated from 25 June 2025 to 15 September 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 18 September 2026, reports an option exercise of €37k in Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. Between a trade and the moment it shows up on SEDI, the median delay is 4 days. Until a filing is published, the market cannot know about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Companies and markets linked to David Kideckel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
300,000 shares@ CA$0.20OptionsTSXSEDI:4778916
3,000,000 sharesRestricted Share UnitsTSXSEDI:4775846
Restricted Share UnitsTSXSEDI:4775845
50,000 shares@ CA$0.200.23% mcap50.0% of flowWarrantsTSXSEDI:4763703
100,000 shares@ CA$0.100.23% mcap50.0% of flowCommon SharesTSXSEDI:4763702
500,000 shares@ CA$0.05100.0% of flowOptionsTSXSEDI:4725820
OptionsTSXSEDI:4725819
7 of 7 declarations
